You are here: GCP training > Menu > Process > Protocol Development

 

3.1 Protocol Development

Back to previous page
BACK

Key information outlined in protocol

  • Introduction and rationale
  • Study objectives and endpoints
  • Study design; inclusion/exclusion criteria; drug dosage and administration
  • Measurements and evaluation
  • Data analysis methods
  • Consent; Unblinding; Indemnity
  • Adverse events and serious adverse events
  • Trial organisation
  • Protocol summary
  • Case study reports (data collection forms)
  • Patient information leaflets & consent forms

ICH guideline E6: Section 6. Clinical Trial Protocol and Protocol amendment(s)

Back to menu
BACK TO MENU